Friday, June 6, 2025

Monthly Archives: June, 2020

Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock

June 26, 2020: "Soleno Therapeutics announced the closing of its previously announced underwritten public offering of 34,848,484 shares of its common stock, including 4,545,454...

Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab

Jun 26, 2020: "The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA®...

Coronavirus (COVID-19) Update: Daily Roundup June 26, 2020

June 26, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part...

FDA provides Biologics License Application for Abicipar pegol

June 26, 2020: "Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol Allergan, an...

Novartis receives positive CHMP opinion for new Xolair® indication to treat chronic rhinosinusitis

Jun 26, 2020: "Novartis announced that the European Medicines Agency's  Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending...

Novartis Cosentyx® gains positive CHMP opinion for pediatric psoriasis

Jun 26, 2020: "Novartis, a leader in immuno-dermatology and rheumatology, announced the Committee for Medicinal Products for Human Use (CHMP) of the EMA has...

What is Phase-I Clinical Trial?

"As we all know in clinical trials are mainly conducted in five phases viz. Phase I, Phase II, Phase III and Phase IV.  Phase...

FDA approves pembrolizumab for cutaneous squamous cell carcinoma

June 24, 2020: The Food and Drug Administration approved pembrolizumab (KEYTRUDA) for patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is...

Coronavirus (COVID-19) Update: Daily Roundup June 25, 2020

June 25, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: A new...

Novartis Resolves Legacy FCPA Investigations

 June 25, 2020: "Novartis has reached settlements with the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) resolving all...

Roche’s Rozlytrek recommended by NICE for cancer

June 25, 2020: "Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug to be recommended by...

Kymab wins Supreme Court case against Regeneron

June 24, 2020:"Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics, is pleased to announce that the Supreme Court of the United...
- Advertisment -

Most Read